XFOR

X4 Pharmaceuticals Inc

May 19 • 04:00PM ET

3.64

-0.04 -1.09 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: COGT MREO SRRK ABEO NRIX

| Held by: VTI VXF AVSC PRFZ BTEC URTY ITWO

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.54	Insider Own	20.85%	Shs Outstand	94.32M	Perf Week	-16.13%
Market Cap	343.32M	Forward P/E	-	EPS next Y	-0.78	Insider Trans	-0.09%	Shs Float	74.65M	Perf Month	-13.13%
Enterprise Value	186.85M	PEG	-	EPS next Q	-0.18	Inst Own	82.79%	Short Float	4.18%	Perf Quarter	21.74%
Income	-99.72M	P/S	38.10	EPS this Y	60.07%	Inst Trans	51.54%	Short Ratio	6.85	Perf Half Y	-0.55%
Sales	9.01M	P/B	2.04	EPS next Y	-4.46%	ROA	-49.82%	Short Interest	3.12M	Perf YTD	-9.00%
Book/sh	1.79	P/C	1.47	EPS next 5Y	31.35%	ROE	-104.21%	52W High	4.83 -24.64%	Perf Year	24.66%
Cash/sh	2.48	P/FCF	-	EPS past 3/5Y	65.48% 54.19%	ROIC	-40.71%	52W Low	1.35 169.63%	Perf 3Y	-94.22%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- 63.56%	Gross Margin	79.04%	Volatility	5.97% 5.99%	Perf 5Y	-98.35%
Dividend TTM	-	EV/Sales	20.74	EPS Y/Y TTM	-300.04%	Oper. Margin	-1084.38%	ATR (14)	0.25	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.98	Sales Y/Y TTM	-71.26%	Profit Margin	-1106.30%	RSI (14)	35.62	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.18	EPS Q/Q	-490.02%	SMA20	-12.65%	Beta	0.31	Target Price	11.67
Payout	-	Debt/Eq	0.46	Sales Q/Q	-90.60%	SMA50	-11.95%	Rel Volume	0.98	Prev Close	3.68
Employees	45	LT Debt/Eq	0.45	Earnings	May 06 BMO	SMA200	-0.14%	Avg Volume	454.85K	Price	3.64
IPO	Nov 16, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	20.00% -22.84%	Trades		Volume	446,986	Change	-1.09%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)